|
Group
|
SJS/TEN
|
Controls
|
|---|
|
Subgroup
|
SJS
|
SJS/TEN overlap
|
TEN
|
|---|
|
No.
|
23
|
2
|
2
|
39
|
|
Age (year), median (range)
|
43.0 (6–79)
| | |
42.2 (6–80)
|
|
Male/female (n)
|
17/10
| | |
25/14
|
|
Outcome (n)
|
A (23)
|
A (2)
|
A (2)
|
A (39)
|
|
Culprit drugs (n [%])
|
|
Identified
|
22 (81.5)
| | | |
|
Carbamazepine
|
7 (25.9)
| | | |
|
Allopurinol
|
6 (22.2)
| | | |
|
Oxcarbazepine
|
2 (7.4)
| | | |
|
TCM
|
1 (3.7)
| | | |
|
Lamotrigine
|
1 (3.7)
| | | |
|
Amoxicillin
|
1 (3.7)
| | | |
|
Diazepam
|
1 (3.7)
| | | |
|
Tamsulosin
|
1 (3.7)
| | | |
|
NSAIDs
|
1 (3.7)
| | | |
|
Unidentified
|
5 (18.5)
| | | |
- A alive, NSAIDs nonsteroidal anti-inflammatory drugs, TCM traditional Chinese medicine
